预防神经病变和改善抗癌化疗,使用一种基于卡巴索尔的化合物
Lauriane Bosc1, Maria Elena Pero2,3, David Balayssac4
1Université Grenoble Alpes, INSERM U1209, CNRS UMR 5309, Institute for Advanced Biosciences (IAB), 38000 Grenoble, France.
Science advances
|October 29, 2025
概括
一种新的化合物Carba1为预防化疗诱导的周围神经病变 (CIPN) 提供了希望. 它通过降低化疗剂量和增强细胞弹性来保护神经,改善癌症患者的生活质量.
科学领域:
- 神经科学是一个神经科学.
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 化疗诱导的周围神经病变 (CIPN) 是癌症治疗的常见,衰弱的,往往无法治疗的副作用.
- 现有的疗法缺乏有效的策略来预防或管理CIPN,严重影响患者的生活质量.
研究的目的:
- 介绍和评估Carba1,一种新型的双功能碳素化合物,作为一种针对CIPN.的神经保护剂.
- 研究Carba1的双重机制:与素的相互作用和NAMPT的激活,以增强神经保护.
主要方法:
- 在实验室中评估Carba1对帕克利塔克塞尔,西斯普拉丁和博尔特佐米布的神经保护作用.
- 在 paclitaxel 诱导的神经病变的小鼠模型中对 Carba1 的体内评估.
- 评估Carba1对paclitaxel抗癌疗效和瘤生长的影响.
主要成果:
- 卡巴1在体外和体内表现出显著的神经保护作用,减轻化疗引起的神经损伤.
- 卡巴1允许降低高剂量,而不会影响抗癌效果.
- 卡巴1激活NAMPT,促进NAD生物合成和细胞代谢弹性,并且不会阻碍化疗的抗瘤能力或促进瘤生长.
结论:
- 卡巴1是预防CIPN的有希望的治疗候选者,提供双重作用机制.
- 卡巴1及其衍生物的开发可以显著改善癌症治疗结果和患者的生活质量.
- 对Carba1衍生物的进一步研究可能会产生具有定制神经保护或双重治疗效果的化合物.
相关概念视频
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
564
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
564
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
801
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
801
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
665
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
665
01:27Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
594
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
594
02:49Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K